PD-L1
Clinical trials for PD-L1 explained in plain language.
Never miss a new study
Get alerted when new PD-L1 trials appear
Sign up with your email to follow new studies for PD-L1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy hopes to boost immune attack on tough pancreatic cancer
Disease control Recruiting nowThis study tests whether adding low-dose radiation and an immunotherapy drug (pultelimab) to standard treatment can help shrink tumors in people with advanced pancreatic cancer. About 10 adults who have not had immunotherapy before will take part. The goal is to see if the combin…
Matched conditions: PD-L1
Phase: PHASE1, PHASE2 • Sponsor: Zhejiang Provincial People's Hospital • Aim: Disease control
Last updated May 26, 2026 05:04 UTC
-
Could a simple scan replace biopsies for cancer detection?
Diagnosis Recruiting nowThis study tests a new type of PET scan (68Ga-NK224) to measure PD-L1 levels in tumors. PD-L1 is a protein that helps some cancers hide from the immune system. The goal is to see if the scan can give the same information as a tissue biopsy, but without the need for surgery. The s…
Matched conditions: PD-L1
Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Diagnosis
Last updated May 26, 2026 04:35 UTC